Table 3.
M + M group (n=35) | M + P group (n=34) | M + E group (n=36) | p-value | |
---|---|---|---|---|
Overall cardiovascular adverse events, n (%) | 8 (22.9) | 5 (14.7) | 6 (16.7) | |
Tachycardia | 6 (17.1) | 3 (8.8) | 5 (13.9) | 0.634 |
Bradycardia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.0 |
Transient hypotension | 2 (5.7) | 2 (5.9) | 1 (2.8) | 0.740 |
Arrhythmia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.0 |
Overall respiratory adverse events, n (%) | 1 (2.8) | 3 (8.8) | 4 (11.1) | 0.434 |
Myoclonus, n (%) | ||||
Occurrence | 0 (0.0) | 0 (0.0) | 3 (8.3) | 0.105 |